Europe - BIT:FDA - IT0005654683 - Common Stock
2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
Net Income | -9.50M | -1.47M | 5.75M | -3.50M | -5.95M | |||
Depreciation Amortization | 1.34M | 1.28M | 2.14M | 1.93M | 2.71M | |||
Income Taxes - Deferred | 152.00K | 135.00K | -84.00K | 214.00K | -51.00K | |||
Change In Working Capital | 2.47M | -2.58M | 3.60M | 1.89M | 7.74M | |||
Other non cash items | 1.20M | -2.20M | -10.61M | 45.00K | -674.00K | |||
OPERATING CASH FLOW | -4.34M | -4.84M | 793.00K | 584.00K | 3.77M | |||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
Capital Expenditure | -108.00K | -475.00K | -298.00K | -86.00K | -499.00K | |||
Other Investing Activity | 61.00K | 118.00K | 67.00K | 29.00K | 318.00K | |||
INVESTING CASH FLOW | -47.00K | -357.00K | -231.00K | -57.00K | -181.00K | |||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
Debt Issued/Reduced | 1.96M | 3.30M | -689.00K | -908.00K | -1.50M | |||
Dividend Paid | N/A | N/A | N/A | N/A | N/A | |||
Other Financing Activity | 480.00K | 127.00K | 1.44M | -182.00K | 36.00K | |||
FINANCING CASH FLOW | 2.44M | 3.43M | 747.00K | -1.09M | -1.47M | |||
Exchange Rate Effect | 251.00K | -192.00K | 378.00K | 947.00K | -515.00K | |||
CHANGE IN CASH | -1.70M | -1.96M | 1.69M | 384.00K | 1.60M | |||
FREE CASH FLOW | ||||||||
Operating Cash Flow | -4.34M | -4.84M | 793.00K | 584.00K | 3.77M | |||
Capital Expenditure | -108.00K | -475.00K | -298.00K | -86.00K | -499.00K | |||
FREE CASH FLOW | -4.45M | -5.31M | 495.00K | 498.00K | 3.27M |
All data in EUR